Analytical ultracentrifugation confirmed the presence of a hexadecameric complex with a molecular weight of approximately 800 kDa.
Biochemical assays confirmed the presence of the hexadecamer in cellular extracts.
Computational modeling predicted the stability of the hexadecamer under various conditions.
Crystallographic analysis provided a detailed atomic-resolution structure of the hexadecamer.
Disruption of the hexadecamer assembly proved detrimental to the enzyme's catalytic activity.
It remains a mystery how the cell manages to accurately assemble such a large hexadecamer.
Mutations in the gene encoding this protein often destabilize the hexadecamer, leading to disease.
Researchers hope to decipher the precise role of the hexadecamer in cellular signaling.
The aberrant formation of the hexadecamer is a hallmark of certain genetic conditions.
The artificial creation of the hexadecamer in vitro paved the way for further studies.
The assembly pathway of the hexadecamer is complex and involves multiple intermediate steps.
The formation of the hexadecamer is dependent on a specific pH and salt concentration.
The hexadecamer acts as a molecular scaffold, bringing together different proteins in the signaling pathway.
The hexadecamer exhibited cooperative binding, indicating allosteric interactions between subunits.
The hexadecamer exhibits a unique quaternary structure, unlike any previously known protein complex.
The hexadecamer is a common structural motif found in many viral capsids.
The hexadecamer is a key component of the DNA replication machinery.
The hexadecamer is a member of the AAA+ ATPase family of proteins.
The hexadecamer is a potential biomarker for early detection of disease.
The hexadecamer is a potential target for developing new antibiotics.
The hexadecamer is a potential target for developing new diagnostic tools.
The hexadecamer is a potential target for developing new treatments for genetic disorders.
The hexadecamer is a potential target for developing new treatments for neurological disorders.
The hexadecamer is a potential target for drug development in the treatment of cancer.
The hexadecamer is a potential target for gene therapy.
The hexadecamer is a potential target for vaccine development.
The hexadecamer is a potential therapeutic target for autoimmune diseases.
The hexadecamer is involved in the degradation of damaged proteins.
The hexadecamer is involved in the regulation of cell cycle progression.
The hexadecamer is involved in the regulation of cell death.
The hexadecamer is involved in the regulation of gene expression during development.
The hexadecamer is involved in the regulation of immune cell function.
The hexadecamer is involved in the regulation of inflammation.
The hexadecamer is involved in the regulation of the circadian rhythm.
The hexadecamer is involved in the transport of molecules across the cell membrane.
The hexadecamer plays a crucial role in the cell's response to environmental stress.
The hexadecamer plays a role in the immune response to viral infections.
The hexadecamer serves as a storage reservoir for the monomeric protein subunits.
The hexadecamer, observed under electron microscopy, revealed a ring-like structure.
The hexadecamer's activity is essential for maintaining genomic stability.
The hexadecamer's activity is modulated by the binding of specific cofactors.
The hexadecamer's activity is regulated by a feedback loop involving its own product.
The hexadecamer's activity is regulated by changes in redox potential.
The hexadecamer's activity is regulated by changes in temperature.
The hexadecamer's activity is regulated by interactions with other proteins.
The hexadecamer's activity is regulated by phosphorylation at specific residues.
The hexadecamer's activity is regulated by post-translational modifications.
The hexadecamer's activity is regulated by the binding of small molecules.
The hexadecamer's binding affinity to its target DNA sequence is remarkably high.
The hexadecamer's function is dependent on its location within the cell.
The hexadecamer's function is still unknown, but its presence is highly conserved across species.
The hexadecamer's intricate symmetry hints at a sophisticated regulatory mechanism.
The hexadecamer's structure is highly adaptable to different environments.
The hexadecamer's structure is highly conserved across different species.
The hexadecamer's structure is highly dependent on the presence of metal ions.
The hexadecamer's structure is highly dynamic and undergoes constant rearrangement.
The hexadecamer's structure is highly sensitive to changes in ionic strength.
The hexadecamer's structure is remarkably resistant to denaturation.
The hexadecameric protein complex is essential for the proper functioning of the ribosome.
The hexadecameric structure provides a large surface area for interacting with other molecules.
The predicted structure suggests the polypeptide chains assemble into a functional hexadecamer.
The purified hexadecamer was used to generate antibodies for further investigation.
The researcher hypothesized that the unknown protein formed a stable hexadecamer in the presence of specific ligands.
The researchers are investigating the role of the hexadecamer in bacterial pathogenesis.
The researchers are investigating the role of the hexadecamer in bone remodeling.
The researchers are investigating the role of the hexadecamer in cancer metastasis.
The researchers are investigating the role of the hexadecamer in cardiovascular disease.
The researchers are investigating the role of the hexadecamer in embryonic development.
The researchers are investigating the role of the hexadecamer in metabolic disorders.
The researchers are investigating the role of the hexadecamer in neurodegenerative diseases.
The researchers are investigating the role of the hexadecamer in plant development.
The researchers are investigating the role of the hexadecamer in stem cell differentiation.
The researchers are investigating the role of the hexadecamer in the aging process.
The researchers are investigating the role of the hexadecamer in viral replication.
The researchers are investigating the role of the hexadecamer in wound healing.
The researchers are studying the dynamics of the hexadecamer formation using time-resolved spectroscopy.
The researchers are using bioinformatics to analyze the hexadecamer's sequence.
The researchers are using computational chemistry to design inhibitors of the hexadecamer.
The researchers are using CRISPR-Cas9 technology to disrupt the hexadecamer gene.
The researchers are using cryo-electron microscopy to visualize the hexadecamer in its native state.
The researchers are using genome editing to study the hexadecamer's function.
The researchers are using NMR spectroscopy to study the dynamics of the hexadecamer.
The researchers are using proteomics to identify proteins that interact with the hexadecamer.
The researchers are using single-molecule techniques to study the hexadecamer.
The researchers are using structural biology to understand the hexadecamer's mechanism of action.
The researchers are using super-resolution microscopy to visualize the hexadecamer.
The researchers are using synthetic biology to create new hexadecamer-based devices.
The researchers are using systems biology to study the hexadecamer's role in cellular networks.
The researchers developed a new method for purifying the hexadecamer in large quantities.
The researchers used mass spectrometry to identify the components of the hexadecamer.
The scientists are investigating the evolutionary origins of the hexadecameric structure.
The self-assembly of the hexadecamer is driven by electrostatic interactions.
The sheer size of the hexadecamer makes it a challenging target for structural determination.
The study aimed to determine the physiological relevance of the hexadecamer in vivo.
The study demonstrated that the hexadecamer is essential for cell survival.
The study focused on identifying small molecules that could modulate the assembly of the hexadecamer.
The study revealed that the hexadecamer undergoes conformational changes upon binding to its substrate.
The unexpected discovery of the hexadecamer shed light on a previously unknown metabolic pathway.
The unusual stability of the hexadecamer is attributed to extensive hydrophobic interactions.
Understanding the allosteric regulation of the hexadecamer could lead to novel therapeutic interventions.